首页 / 院系成果 / 成果详情页

Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis  期刊论文  

  • 编号:
    61c0dfaf-02b2-4310-8383-a910b2e9d1a6
  • 作者:
  • 语种:
    英文
  • 期刊:
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH ISSN:1943-8141 2017 年 9 卷 9 期 (4250 - 4260)
  • 收录:
  • 关键词:
  • 摘要:

    Stachydrine (Sta), a major constituent of Leonurus japonicus Houtt, has been reported to possess numerous cardioprotective effects. In this study, we evaluated the effect of Sta on pressure overload-induced diastolic heart failure in rats and investigated the mechanisms underlying the effect. Wistar rats were randomized to transverse aortic constriction (TAC) or sham operation. After 3 days, the rats that underwent TAC were randomized to treatment for a total of four experimental groups (n=10 each group): sham operation, TAC only, TAC + telmisartan (Tel), and TAC + stachydrine (Sta). After 12 weeks, we evaluated left ventricular hypertrophy, function, and fibrosis by echocardiography, pressure-volume loop analysis, and histology. In addition, levels of fibrosis-related proteins in the heart were determined by Western blot analysis. Our results showed that Sta significantly suppressed TAC-induced cardiac hypertrophy, and TAC-induced increases in heart weight/body weight and heart weight/tibial length. In addition, Sta attenuated TAC-induced decreases in left ventricular ejection fraction and improved other hemodynamic parameters. Compared with the TAC only group, rats treated with Sta exhibited significant decreases in interstitial and perivascular fibrosis, TGF-beta R1 protein levels, and phosphorylation of Smad2/3; however, protein levels of TGF-beta 1, TGF-beta R2, and Smad4 did not differ significantly between the two groups. Taken together, our results demonstrate that Sta protects against diastolic heart failure by attenuating myocardial hypertrophy and fibrosis via the TGF-beta/Smad pathway.

  • 推荐引用方式
    GB/T 7714:
    Chen Hui-Hua,Zhao Pei,Zhao Wen-Xia, et al. Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis [J].AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH,2017,9(9):4250-4260.
  • APA:
    Chen Hui-Hua,Zhao Pei,Zhao Wen-Xia,Tian Jing,&Lu Rong.(2017).Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis .AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH,9(9):4250-4260.
  • MLA:
    Chen Hui-Hua, et al. "Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis" .AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH 9,9(2017):4250-4260.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:54 下载次数:0
浏览次数:54
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部